Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Long-term Debt / Equity

Amneal Pharmaceuticals Inc Long-term Debt / Equity Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Long-term Debt / Equity from 2018 to 2018.
  • Amneal Pharmaceuticals Inc Long-term Debt / Equity for the quarter ending December 12, 2018 was $298m
  • Amneal Pharmaceuticals Inc Long-term Debt / Equity for the last 12 months ending December 12, 2018 was $298m
Other Ratios Metrics:
  • Amneal Pharmaceuticals Inc Total Debt / Capital for the quarter ending December 12, 2018 was $75m a -77.49% decrease of -58m year over year
  • Amneal Pharmaceuticals Inc Other Liabilities for the quarter ending December 12, 2018 was $233m a 90.39% increase of 210m year over year
  • Amneal Pharmaceuticals Inc Total Debt / Equity for the quarter ending December 12, 2018 was $300m
View Chart On Koyfin

Quarterly AMRX Long-term Debt / Equity Data

12/2018$298m
09/2018$292m
06/2018$282m

Annual AMRX Long-term Debt / Equity Data

2018$298m